Systematic review of the clinical effectiveness and cost-effectiveness of capecitabine (Xeloda) for locally advanced and/or metastatic breast cancer.

L Jones, N Hawkins, M Westwood, K Wright, G Richardson, R Riemsma

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1-143
Number of pages143
JournalHealth technology assessment
Issue number5
Publication statusPublished - 2004

Cite this